Common TitleERCHIVES-Renal: OPRD
Official Title Effectiveness, Treatment Completion and Safety of Sofosbuvir-Ledipasvir and Paritaprevir-Ritonavir-Ombitasvir plus Dasabuvir in Patients with Chronic Kidney Disease: an ERCHIVES Study.
Treatments
Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir
Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir
Tradename:Viekira PakOther Names:3DClass:DiscontinuedFunding
IndustryGilead Sciences
Non-IndustryVA Pittsburgh Healthcare System.